As it stated in freep
Thousands walk in Detroit's Hart Plaza for breast cancer research
Thousands walk in Detroit's Hart Plaza for breast cancer research
Detroiters Lauren Kindred and Tamara Williams pose for a photo at the Making Strides Against Breat Cancer walk from Hart Plaza to Joe Louis Arena in Detroit on Oct 8, 2016.Lauren, left, has a cousin celebrating her 10th cancer-free year.Tamara, right, has an aunt who is also a survivor.(Photo: Lex Dodson, Special to the Free Press)When Laura Larkins went through radiation treatments over the past two years for breast cancer, it wasn't easy.
coupled with abc57
Pink Out Zumba brings breast cancer survivors together
Pink Out Zumba brings breast cancer survivors together
As the head coach, Brian Kelly is used to being the one calling the plays for his football team.But not everyone knows his wife Paqui has a playbook and a team of her own.It's called "Pink Out Zumba" and it's an event right out of Paqui's Playbook."It was amazing.
coupled with tnp
Shop sells clothes designed for breast cancer patients
Shop sells clothes designed for breast cancer patients
October is Breast Cancer Awareness Month.We speak to the owner of Can-Care, a one-stop shop for breast cancer patients to rediscover their inner beautyIt is a little shop for the soul, inconspicuous among the glitzy shops selling luxury goods and the latest threads in neighbouring shopping malls.Can-Care, on the sixth storey of Orchard Shopping Centre, caters to female breast cancer patients.The shop sells everything, such as wigs and headwear for chemotherapy patients and silicone prosthetic breast forms for those who have had a mastectomy.
in the same way eurekalert
Targeting estrogen receptor improves progression-free survival in advanced breast cancer
Targeting estrogen receptor improves progression-free survival in advanced breast cancer
LUGANO-COPENHAGEN, 8 October 2016.Fulvestrant significantly increases progression-free survival in women with hormone-receptor-positive advanced breast cancer, particularly those with less aggressive lower-volume disease, researchers reported at the ESMO 2016 Congress in Copenhagen1.Fulvestrant is a selective estrogen receptor degrader that targets the function of the hormone receptor so, unlike aromatase inhibitors such as anastrozole, it does not interfere with estrogen levels themselves.The randomized, double-blind, multi-center phase III trial enrolled 462 women with inoperable locally-advanced or metastatic ER-positive, HER-negative breast cancer, who had not received prior hormone therapy.
No comments:
Post a Comment